Tempus AI has announced that it is using the TIME Network for Phase I trials to expedite site activation and enrolment.

The rate of surgical overtreatment of low-risk prostate cancer showed a significant decline between 2010 and 2024, reflecting ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, is leveraging its TIME Network to expand its support in phase I clinical ...

In this video, I will talk about Tempus AI (NASDAQ: TEM) and whether it is worth buying after the recent pullback. Watch the ...

This article explains whether Cathie Wood’s flagship ARKK ETF fund is a good investment as it bounces back after crashing ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced Tempus Loop, a new oncology-focused platform for target ...

We recently published a list of Why These 10 Firms Recorded Double-Digit Gains Last Week. In this article, we are going to ...

Tempus AI TEM has skyrocketed 21% in the last three days, fueled by news of a $200 million partnership with AstraZeneca AZN ...

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $63.78, ...

Tempus AI (TEM) has seen a significant surge on Wednesday, with its stock climbing 14.62% in just one day. The significant boost in TEM stock ...

With the stock market in rally mode, there are more pockets of strength than there have been in a while. Among the winners ...

Many of America’s wealthiest business leaders have lost millions, if not billions, of dollars in net worth since the start of the year, as President Donald Trump’s policies hit markets. But some might ...